BBIO
$9.04
Bridgebio Pharma
$.09
1.01%
BBIO
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.80)
Revenue:  $23.99 Mil
Thursday
Feb 24
7:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BBIO reports earnings?
Beat
Meet
Miss

Where is BBIO's stock price going from here?
Up
Flat
Down
Stock chart of BBIO
Analysts
Summary of analysts' recommendations for BBIO
Score
Grade
Pivots
Resistance
$9.92
$9.51
$9.28

$8.87

Support
$8.63
$8.22
$7.99
Tweet
Growth
Description
BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.